Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up—the Hjørring project

References

• Aksu M. F., Tzingounis V. A., Greenblatt R. B. Treatment of benign breast disease with danazol: A follow-up report. J Reprod Med 1978; 21: 181
   Google Scholar
• Asch R. H., Fernandez E. D., Siler-Khodr T. M., Bartke A., Pauerstein C. J. Mechanism of induction of luteal phase defects by danazol. Am J Obstet Gynecol 1980; 136: 932
   Google Scholar
• Asch R. H., Greenblatt R. B. The use of an impeded androgen—danazol—in the management of benign breast disorders. Am J Obstet Gynecol 1977; 127: 130
   Google Scholar
• Barbieri R. L., Lee H., Ryan K. J. Danazol binding to rat androgen, glucocorticoid, progesterone and androgen receptors: Correlation with biologic activity. Fertil Steril 1979; 31: 182
   PubMed Web of Science ®Google Scholar
• Blackmore W. P. Danazol in the treatment of benign breast disease. J Int Med Res 1977; 5(Suppl. 3)101
   Google Scholar
• Blackmore W. P. Results of the clinical evaluation of danazol in fibrocystic breast disease. Paper read at a Symposium on Fibrocystic Breast Disease, Washington, D. C., May, 1979
   Google Scholar
• Brookshaw J. D. Danazol treatment in benign breast disease: A survey of U. S. A. multicentre studies. Postgrad Med J 1979; 55(Suppl. 5)52
   Google Scholar
• Carlström K., Döberl A., Gershagen S., Rannevik G., Rasmussen Th, Tobiassen T. Elevated peripheral levels of androgens and of some steroid sensitive plasma proteins in patients with severe fibrocystic breast disease. A preliminary report. Acta Obstet Gynecol Scand 1984, Suppl 123: 157
   Google Scholar
• Carlström K., Döberl A., Gershagen S., Rannevik G. Peripheral levels of dehydroepiandrosterone sulfate, dehydroepiandrosterone, androstenedione, and testosterone following different doses of danazol. Acta Obstet Gynecol Scand 1984, Suppl 123: 125
   Google Scholar
• Chamness G. C., Asch R. H., Pauerstein C. J. Danazol binding and translocation of steroid receptors. Am J Obstet Gynecol 1980; 136: 426
   Google Scholar
• Dhont M., Delbeke L., van Eyck J., Voorhoof L. Danazol treatment of chronic cystic mastopathy: A clinical and hormonal evaluation. Postgrad Med J 1979; 55(Supp1.5)66
   Google Scholar
• Dmowski W. P., Headly S., Radwanska E. Effect of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women. Fertil Steril 1983; 39: 49
   PubMed Web of Science ®Google Scholar
• Döberl A., Tobiassen T., Rasmussen Th. Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. A double blind placebo controlled study—the Hjørring project. Acta Obstet Gynecol Scand 1984, Suppl 123: 177
   Google Scholar
• Gershagen S., Döberl A., Rannevik G. Changes in the SHBG concentration during danazol treatment. Acta Obstet Gynecol Scand 1984, Suppl 123: 117
   Google Scholar
• Greenblatt R. B. Danazol and fibrocystic breast disease: Results of clinical evaluation in Georgia. Paper read at a Symposium on Fibrocystic Breast Disease, Washington, D. C., May, 1979
   Google Scholar
• Greenblatt R. B., Nezhat C., Ben-Nun I. The treatment of benign breast disease with danazol. Fertil Steril 1980; 34: 242
   Google Scholar
• Henderson K. M., Tsang B. K. Danazol suppresses luteal function in vitro and in vivo. Fertil Steril 1980; 33: 550
   Google Scholar
• Krey L. C., Robbins R., McEwen B. S. Danazol suppression of luteinizing hormone secretion: A role for danazol—androgen receptor interaction within the brain-pituitary complex. Fertil Steril 1981; 35: 467
   Google Scholar
• Lauersen N. H., Wilson K. H. The effect of danazol in the treatment of chronic cystic mastitis. Obstet Gynecol 1976; 48: 93
   Google Scholar
• Laurell C B., Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens. J C E M 1979; 49: 719
   Google Scholar
• Manse1 R. E., Wisbey J. R., Hughes L. E. Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet 1982; i: 928
   Google Scholar
• Menon M., Azhar S., Menon K. M. J. Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin—receptor interaction and adenosine 3′,5′ cyclic monophosphate formation. Am J Obstet Gynecol 1980; 136: 524
   PubMedGoogle Scholar
• Nezhat C., Asch R. H., Greenblatt R. B. Danazol for benign breast disease. Am J Obstet Gynecol 1980; 137: 604
   PubMed Web of Science ®Google Scholar
• Nilsson L., Dennefors B., Olsson J H., Hillensjö T., Rannevik G. In vitro effects of danazol on steroidogenesis in developing human follicles—an interim report. Acta Obstet Gynecol Scand 1984, Suppl 123: 99
   Google Scholar
• Ouimet-Oliva D., Van Compenhout J., Hébert G., Ladouceur J. Effect of danazol on the radiographic density of breast parenchyma. J Canad Ass Radiol 1981; 32: 159
   Google Scholar
• Pavelka R., Schneider W. H. F. Klinische Erfahrungen mit Danazoltherapie bei Endometriose und Mastopathie. Wr Klin Wschr 1981; 93: 595
   PubMedGoogle Scholar
• Pugeat M. M., Dunn J. F., Nisula B. C. Transport of steroid hormones: Interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J C E M 1981; 53: 69
   Google Scholar
• Rannevik G. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis. Postgrad Med J 1979; 55(Suppl. 5)14
   Google Scholar
• Rannevik G., Döberl A., Gershagen S., Rasmussen Th, Tobiassen T. Elevated serum concentrations of sex hormone binding globulin in fibrocystic breast disease. Endocrinology of Cystic Breast Disease, A. Angeli, H. L. Bradlow, L. Dogliotti. Raven Press, New York 1983; 127
   Google Scholar
• Rannevik G., Thorell J. I. The influence of danazol on the pituitary function and on the ovarian follicular hormone secretion in premenopausal women. Acta Obstet Gynecol Scand 1984, Suppl 123: 89
   Google Scholar
• Rasmussen Th, Tobiassen T. Patient characteristics and age-dependent sub-populations in severe fibrocystic breast disease—the Hjørring project. Acta Obstet Gynecol Scand 1984, Suppl 123: 151
   Google Scholar
• Shane J. M., Kates R., Barbieri R. L., Todd R. B., Davies I. J. Pituitary gonadotropin responsiveness with danazol. Fertil Steril 1978; 29: 637
   Google Scholar
• Strax P. Danazol and fibrocystic breast disease: Results of clinical evaluation at the Guttman Institute, New York City. Paper read at a Symposium on Fibrocystic Breast Disease, Washington, D. C., May, 1979
   Google Scholar
• Tamaya T., Furuta N., Motoyama T., Boku S., Ohono Y., Okada H. Mechanism of antiprogestational action of synthetic steroids. Acta Endocr 1978; 88: 190
   Google Scholar
• Thorell J. I., Dymling J. F., Rannevik G. Effect of danazol on thyroid function in women. Postgrad Med J 1979; 55(Suppl. 5)33
   Google Scholar